137 related articles for article (PubMed ID: 21119036)
1. Commentary.
Milone MC
Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
[No Abstract] [Full Text] [Related]
2. Commentary.
Fox E; Balis FM
Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
[No Abstract] [Full Text] [Related]
3. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
Al-Turkmani MR; Law T; Narla A; Kellogg MD
Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
[No Abstract] [Full Text] [Related]
4. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
[TBL] [Abstract][Full Text] [Related]
6. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
Estève MA; Devictor-Pierre B; Galy G; André N; Coze C; Lacarelle B; Bernard JL; Monjanel-Mouterde S
Eur J Clin Pharmacol; 2007 Jan; 63(1):39-42. PubMed ID: 17115148
[No Abstract] [Full Text] [Related]
7. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
[TBL] [Abstract][Full Text] [Related]
8. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
9. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
[TBL] [Abstract][Full Text] [Related]
10. Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma.
Escobosa Sánchez OM; Herrero Hernández A; Ortega Acosta MJ; Camacho Alonso J; Milano Manso G; Acha García T
Clin Transl Oncol; 2006 May; 8(5):379-80. PubMed ID: 16760016
[No Abstract] [Full Text] [Related]
11. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
[TBL] [Abstract][Full Text] [Related]
12. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
[No Abstract] [Full Text] [Related]
13. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR
Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103
[TBL] [Abstract][Full Text] [Related]
14. [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].
von Poblozki A; Dempke W; Schmoll HJ
Med Klin (Munich); 2000 Aug; 95(8):457-60. PubMed ID: 10985069
[TBL] [Abstract][Full Text] [Related]
15. Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate.
Shinozaki T; Watanabe H; Tomidokoro R; Yamamoto K; Horiuchi R; Takagishi K
Med Pediatr Oncol; 2000 Mar; 34(3):226-8. PubMed ID: 10696135
[No Abstract] [Full Text] [Related]
16. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
[TBL] [Abstract][Full Text] [Related]
17. Using a lower dose of glucarpidase to reduce plasma levels of methotrexate.
Widemann BC
Clin Adv Hematol Oncol; 2013 May; 11(5):324-5. PubMed ID: 23880720
[No Abstract] [Full Text] [Related]
18. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
Heuschkel S; Kretschmann T; Teipel R; von Bonin S; Richter S; Quick S; Alakel N; Röllig C; Balaian E; Kroschinsky F; Knoth H; Bornhäuser M; von Bonin M
Cancer Chemother Pharmacol; 2022 Jan; 89(1):41-48. PubMed ID: 34669022
[TBL] [Abstract][Full Text] [Related]
19. Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high-dose methotrexate.
Schafer ES; Bernhardt MB; Reichert KE; Haworth TE; Shah MD
Am J Hematol; 2018 Feb; 93(2):E40-E42. PubMed ID: 29119597
[No Abstract] [Full Text] [Related]
20. [Acute toxicity of high doses of methotrexate in treatment of ALL in children: a case study].
Periáñez-Párraga L; Pérez-Rodríguez O; do Pazo-Oubiña F; Crespí-Monjo M
Farm Hosp; 2009; 33(3):172-3. PubMed ID: 19712601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
